Lv5
1200 积分 2021-12-10 加入
Targeting the future: Antibody-Drug Conjugates (ADCs) in platinum-sensitive ovarian cancer in the post-PARP era
2个月前
已关闭
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies
2个月前
已完结
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT‐cx11/GOG‐3047/KEYNOTE‐A18 trial practice changing?
2个月前
已完结
Enfortumab Vedotin-ejfv: A First-in-Class Anti–Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma
8个月前
已完结
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
8个月前
已完结
Novel antibody-drug conjugate based on DXd-ADC technology
8个月前
已完结
Antibody-drug conjugates for targeted cancer therapy: recent advances in potential payloads
8个月前
已完结
An FDA oncology analysis of antibody-drug conjugates
8个月前
已完结
IgA nephropathy
9个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
9个月前
已完结
Abstract 4752: Preclinical development and translational research on a novel antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells
10个月前
已采纳
Supplementary Data from Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells
10个月前
已采纳
Amivantamab plus Lazertinib Is Efficacious in Non–Small Cell Lung Cancer
10个月前
已采纳
Optimus-Era Dose Finding for Rare Cancers
10个月前
已采纳
Abstract C036: Cancer associated fibroblasts are regulators of the tumor microenvironment in human pancreatic ductal adenocarcinoma
10个月前
已采纳
Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03
10个月前
已采纳
Abstract 6273: CTS3157, a novel MTA-cooperative PRMT5 inhibitor for targeting MTAP-deleted human tumors
10个月前
已采纳
Data from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
10个月前
已采纳
Venetoclax induces BCL-2–dependent Treg to TH17 plasticity to enhance the antitumor efficacy of anti–PD-1 checkpoint blockade
10个月前
已采纳
A 5-hydroxymethylcytosine-based non-invasive model for early detection of colorectal carcinomas and advanced adenomas: the METHOD-2 study
10个月前
已采纳
皖公网安备34019202002308
